medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (4)


Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates

Mendizabal M, Goldberg DS, Piñero F, Arufe DT, de la Fuente MJ, Testa P, Coronel M, Baratta S, Podestá LG, Fallon MB, Silva MO

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 548-554
Archivo PDF: 158.36 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB, ERS Task Force Pulmonary-Hepatic Vascular Disorders PHD Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24: 861-80.

  2. Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome. Clin Gastroenterol Hepatol 2007; 5: 749-54.e1.

  3. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Saha VH, et al. Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates. Gastroenterology 2008; 135: 1168-75.

  4. Pascasio JM, Grilo I, López-Pardo FJ, Ortega-Ruiz F, Tirado JL, Sousa JM, Rodriguez-Puras MJ, et al. Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation. Am J Transplant 2014; 14: 1391-9.

  5. Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopul- monary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042-52.

  6. Kochar R, Tanikella R, Fallon MB. Serial Pulse Oximetry in Hepatopulmonary Syndrome. Dig Dis Sci 2011; 56: 1862-8.

  7. Gupta S, Nayyar D, Pomier-Layrargues G. Variability of Oxygenation in Possible Hepatopulmonary Syndrome: Effects of Requiring Two Abnormal Arterial Blood Gas Results for Diagnosis. Dig Dis Sci 2015; 60: 1848-55.

  8. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, and STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-7.

  9. Krowka MJ. Management of Pulmonary Complications in Pretransplant Patients. Clin Liver Dis 2011; 15: 765-77.

  10. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MAE, Sitbon O, et al.: International Liver Transplant Society Practice Guidelines. Transplantation 2016; 100: 1440-52.

  11. Kanber GJ, King FW, Eschar YR, Sharp JT. The alveolar-arterial oxygen gradient in young and elderly men during air and oxygen breathing. The American Review of Respiratory Disease 1968; 97: 376-81.

  12. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (Baltimore, Md) 2005; 41: 1122-9.

  13. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, Müller C: Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002; 51: 853-9.

  14. Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, et al. Genetic Risk Factors for Hepatopulmonary Syndrome in Patients With Advanced Liver Disease. Gastroenterology 2010; 139: 130-9.e24.

  15. Agarwal PD, Hughes PJ, Runo JR, Ibrisim D, Lucey MR, Said A. The clinical significance of intrapulmonary vascular dilations in liver transplant candidates. Clin Transplant 2012; 27: 148-53.

  16. Gupta S, Castel H, Rao RV, Picard M, Lilly L, Faughnan ME, Pomier-Layrargues: Improved Survival After Liver Transplantation in Patients with Hepatopulmonary Syndrome. Am J Transplant 2010; 10: 354-63.




2020     |     www.medigraphic.com